Xortx Therapeutics Stock Price History
XRTX Stock | USD 1.19 0.03 2.59% |
Below is the normalized historical share price chart for XORTX Therapeutics extending back to November 28, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of XORTX Therapeutics stands at 1.19, as last reported on the 17th of December 2024, with the highest price reaching 1.25 and the lowest price hitting 1.15 during the day.
If you're considering investing in XORTX Stock, it is important to understand the factors that can impact its price. XORTX Therapeutics shows Sharpe Ratio of -0.061, which attests that the company had a -0.061% return per unit of risk over the last 3 months. XORTX Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XORTX Therapeutics' Mean Deviation of 4.48, standard deviation of 6.39, and Market Risk Adjusted Performance of (0.25) to validate the risk estimate we provide.
At this time, XORTX Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 6.1 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 3.1 M in 2024. . Price Earnings Ratio is likely to drop to -1.59 in 2024. Price Book Value Ratio is likely to drop to 0.89 in 2024. XORTX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of November 2018 | 200 Day MA 2.3314 | 50 Day MA 1.5809 | Beta (0.21) |
XORTX |
Sharpe Ratio = -0.061
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | XRTX |
Estimated Market Risk
6.44 actual daily | 57 57% of assets are less volatile |
Expected Return
-0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average XORTX Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XORTX Therapeutics by adding XORTX Therapeutics to a well-diversified portfolio.
Price Book 1.7979 | Book Value 2.322 | Enterprise Value 1.6 M | Enterprise Value Ebitda 0.0864 | Shares Float 2.7 M |
XORTX Therapeutics Stock Price History Chart
There are several ways to analyze XORTX Stock price data. The simplest method is using a basic XORTX candlestick price chart, which shows XORTX Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 16, 2024 | 2.17 |
Lowest Price | December 6, 2024 | 1.15 |
XORTX Therapeutics December 17, 2024 Stock Price Synopsis
Various analyses of XORTX Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell XORTX Stock. It can be used to describe the percentage change in the price of XORTX Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of XORTX Stock.XORTX Therapeutics Price Daily Balance Of Power | 0.30 | |
XORTX Therapeutics Price Rate Of Daily Change | 1.03 | |
XORTX Therapeutics Price Action Indicator | 0.01 |
XORTX Therapeutics December 17, 2024 Stock Price Analysis
XORTX Stock Price History Data
The price series of XORTX Therapeutics for the period between Wed, Sep 18, 2024 and Tue, Dec 17, 2024 has a statistical range of 1.02 with a coefficient of variation of 15.41. The daily prices for the period are distributed with arithmetic mean of 1.48. The median price for the last 90 days is 1.52. The company experienced 1:9 stock split on 14th of November 2023. XORTX Therapeutics paid out dividends to its shareholders on Jan 31, 2014.Open | High | Low | Close | Volume | ||
12/17/2024 | 1.23 | 1.25 | 1.15 | 1.19 | ||
12/13/2024 | 1.23 | 1.25 | 1.15 | 1.19 | 25,615 | |
12/12/2024 | 1.22 | 1.25 | 1.15 | 1.16 | 29,400 | |
12/11/2024 | 1.16 | 1.21 | 1.16 | 1.21 | 9,698 | |
12/10/2024 | 1.19 | 1.25 | 1.16 | 1.19 | 31,038 | |
12/09/2024 | 1.19 | 1.19 | 1.18 | 1.18 | 6,538 | |
12/06/2024 | 1.15 | 1.23 | 1.13 | 1.15 | 12,761 | |
12/05/2024 | 1.18 | 1.25 | 1.12 | 1.17 | 16,897 | |
12/04/2024 | 1.29 | 1.30 | 1.14 | 1.17 | 31,455 | |
12/03/2024 | 1.23 | 1.32 | 1.20 | 1.20 | 12,178 | |
12/02/2024 | 1.40 | 1.40 | 1.24 | 1.33 | 18,495 | |
11/29/2024 | 1.27 | 1.32 | 1.27 | 1.27 | 7,887 | |
11/27/2024 | 1.16 | 1.27 | 1.15 | 1.21 | 12,298 | |
11/26/2024 | 1.23 | 1.28 | 1.15 | 1.18 | 12,032 | |
11/25/2024 | 1.23 | 1.28 | 1.20 | 1.20 | 13,043 | |
11/22/2024 | 1.26 | 1.29 | 1.21 | 1.22 | 13,079 | |
11/21/2024 | 1.26 | 1.28 | 1.25 | 1.26 | 7,124 | |
11/20/2024 | 1.32 | 1.32 | 1.24 | 1.26 | 13,143 | |
11/19/2024 | 1.28 | 1.35 | 1.23 | 1.30 | 27,573 | |
11/18/2024 | 1.28 | 1.31 | 1.20 | 1.23 | 11,189 | |
11/15/2024 | 1.35 | 1.39 | 1.25 | 1.29 | 7,829 | |
11/14/2024 | 1.33 | 1.40 | 1.27 | 1.40 | 7,620 | |
11/13/2024 | 1.35 | 1.39 | 1.28 | 1.30 | 12,763 | |
11/12/2024 | 1.38 | 1.41 | 1.30 | 1.30 | 32,791 | |
11/11/2024 | 1.48 | 1.57 | 1.39 | 1.40 | 55,401 | |
11/08/2024 | 1.42 | 1.63 | 1.40 | 1.54 | 14,300 | |
11/07/2024 | 1.46 | 1.55 | 1.45 | 1.45 | 16,145 | |
11/06/2024 | 1.45 | 1.55 | 1.41 | 1.45 | 13,087 | |
11/05/2024 | 1.35 | 1.60 | 1.35 | 1.40 | 24,118 | |
11/04/2024 | 1.40 | 1.40 | 1.35 | 1.35 | 6,370 | |
11/01/2024 | 1.42 | 1.49 | 1.29 | 1.43 | 11,700 | |
10/31/2024 | 1.46 | 1.47 | 1.37 | 1.43 | 31,060 | |
10/30/2024 | 1.54 | 1.54 | 1.45 | 1.48 | 10,294 | |
10/29/2024 | 1.54 | 1.61 | 1.44 | 1.52 | 17,600 | |
10/28/2024 | 1.56 | 1.62 | 1.54 | 1.56 | 8,966 | |
10/25/2024 | 1.60 | 1.64 | 1.55 | 1.55 | 10,930 | |
10/24/2024 | 1.54 | 1.64 | 1.50 | 1.50 | 43,646 | |
10/23/2024 | 1.60 | 1.71 | 1.54 | 1.58 | 31,973 | |
10/22/2024 | 1.80 | 1.80 | 1.52 | 1.55 | 43,456 | |
10/21/2024 | 1.92 | 1.99 | 1.65 | 1.71 | 52,867 | |
10/18/2024 | 1.88 | 2.03 | 1.86 | 1.88 | 51,752 | |
10/17/2024 | 2.03 | 2.09 | 1.81 | 1.82 | 73,700 | |
10/16/2024 | 1.84 | 2.35 | 1.62 | 2.17 | 313,372 | |
10/15/2024 | 1.52 | 2.51 | 1.51 | 1.87 | 1,552,798 | |
10/14/2024 | 1.56 | 1.58 | 1.51 | 1.52 | 11,708 | |
10/11/2024 | 1.62 | 1.65 | 1.53 | 1.53 | 27,548 | |
10/10/2024 | 1.60 | 1.73 | 1.53 | 1.56 | 38,440 | |
10/09/2024 | 1.81 | 1.81 | 1.64 | 1.70 | 44,603 | |
10/08/2024 | 1.52 | 1.94 | 1.52 | 1.80 | 157,854 | |
10/07/2024 | 1.56 | 1.59 | 1.53 | 1.53 | 6,800 | |
10/04/2024 | 1.63 | 1.70 | 1.51 | 1.54 | 58,608 | |
10/03/2024 | 1.52 | 1.60 | 1.52 | 1.53 | 20,747 | |
10/02/2024 | 1.59 | 1.62 | 1.52 | 1.54 | 12,621 | |
10/01/2024 | 1.71 | 1.71 | 1.52 | 1.55 | 16,551 | |
09/30/2024 | 1.58 | 1.67 | 1.56 | 1.64 | 7,989 | |
09/27/2024 | 1.67 | 1.67 | 1.55 | 1.55 | 7,034 | |
09/26/2024 | 1.72 | 1.72 | 1.50 | 1.52 | 45,760 | |
09/25/2024 | 1.67 | 1.73 | 1.55 | 1.71 | 7,579 | |
09/24/2024 | 1.65 | 1.73 | 1.57 | 1.64 | 31,644 | |
09/23/2024 | 1.68 | 1.73 | 1.62 | 1.64 | 20,393 | |
09/20/2024 | 1.77 | 1.78 | 1.70 | 1.75 | 10,080 |
About XORTX Therapeutics Stock history
XORTX Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XORTX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XORTX Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XORTX Therapeutics stock prices may prove useful in developing a viable investing in XORTX Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2 M | 2.1 M | |
Net Loss | -8.5 M | -8.1 M |
XORTX Therapeutics Stock Technical Analysis
XORTX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
All Next | Launch Module |
XORTX Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XORTX Therapeutics' price direction in advance. Along with the technical and fundamental analysis of XORTX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XORTX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.46) | |||
Total Risk Alpha | (1.02) | |||
Treynor Ratio | (0.26) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.